Reuters (December 2)
2021/ 12/ 02 by jd in Global News
“The good news is that drugmakers are already increasing their manufacturing capacity, which should reduce vaccine hoarding.” Moderna, J&J, AstraZeneca and Pfizer “are expected to produce 12 billion doses between them next year, enough to give two jabs to 75% of the world’s population.” The bad news is “getting shots into arms is a bigger challenge. Many developing countries lack the trained staff to administer doses, or the kit and infrastructure to ship them in the right conditions.”
Tags: AstraZeneca, Capacity, Challenge, Developing countries, Drugmakers, Infrastructure, J&J, Moderna, Pfizer, Trained staff, Vaccine hoarding
